These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2262069)

  • 1. Acute and chronic effects of cyclosporine A on pancreatic polyamine metabolism and pancreatic adaptation.
    Löser C; Alves F; Stöckmann F; Fölsch UR; Creutzfeldt W
    Digestion; 1990; 46 Suppl 2():367-77. PubMed ID: 2262069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of various intracellular regulatory mechanisms of polyamine metabolism in camostate-induced pancreatic growth in rats.
    Löser C; Fölsch UR
    Digestion; 1993; 54(4):213-23. PubMed ID: 8243835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ornithine decarboxylase and polyamines in camostate (Foy-305)-induced pancreatic growth in rats.
    Löser C; Fölsch UR; Cleffmann U; Nustede R; Creutzfeldt W
    Digestion; 1989; 43(1-2):98-112. PubMed ID: 2509268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of intracellular S-adenosylmethionine decarboxylase activity for the regulation of camostate-induced pancreatic polyamine metabolism and growth: in vivo effect of two novel S-adenosylmethionine decarboxylase inhibitors.
    Löser C; Fitting T; Fölsch UR
    Digestion; 1997; 58(3):258-65. PubMed ID: 9243121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of extracellular, dietary putrescine is an important regulatory mechanism of intracellular polyamine metabolism during camostate-induced pancreatic growth in rats.
    Löser C; Torff L; Fölsch UR
    Dig Dis Sci; 1997 Mar; 42(3):503-13. PubMed ID: 9073131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ornithine decarboxylase and polyamine biosynthesis in pancreatic adaptation.
    Löser C; Cleffmann U; Alves F; Fölsch UR; Creutzfeldt W
    Adv Exp Med Biol; 1988; 250():379-88. PubMed ID: 3255234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent inhibition by cyclosporine A of the induction of pancreatic ornithine decarboxylase (ODC) in rats.
    Löser C; Stöckmann F; Fölsch UR; Creutzfeldt W
    Int J Pancreatol; 1989 Sep; 5(2):179-89. PubMed ID: 2600452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
    Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W
    Digestion; 1989; 44(2):105-16. PubMed ID: 2612749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
    Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
    Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of trypsin inhibitor (camostate) on pancreas and CCK release in young and old female rats.
    Miyasaka K; Nakamura R; Kitani K
    J Gerontol; 1989 Jul; 44(4):M136-40. PubMed ID: 2738309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CCK-response to proteinase inhibitor feeding after induction of pancreatic hypertrophy in rats.
    Göke B; Fenchel K; Knobloch S; Arnold R; Adler G
    Pancreas; 1988; 3(5):576-9. PubMed ID: 3186685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ornithine decarboxylase and polyamines in cholecystokinin-induced pancreatic growth in rats: effects of alpha-difluoromethylornithine and the CCK receptor antagonist L-364,718.
    Löser C; Fölsch UR; Sahelijo-Krohn P; Creutzfeldt W
    Eur J Clin Invest; 1989 Oct; 19(5):448-58. PubMed ID: 2479558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissimilar effect of the carcinogenic agent azaserine on pancreatic and hepatic polyamine metabolism in rats.
    Löser C; Stüber E; Fölsch UR
    Pancreas; 1995 Jan; 10(1):44-52. PubMed ID: 7899459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissimilar activation patterns of the carcinogen dimethylhydrazine (DMH) on intracellular polyamine metabolism in various organs.
    Löser C; Starp F; Fölsch UR
    Z Gastroenterol; 1996 Dec; 34(12):801-8. PubMed ID: 9017896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
    Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
    Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
    Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
    Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyamines in pancreatic growth.
    Fölsch UR; Löser C; Alves F
    Digestion; 1990; 46 Suppl 2():345-51. PubMed ID: 2262066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate).
    Göke B; Printz H; Koop I; Rausch U; Richter G; Arnold R; Adler G
    Pancreas; 1986; 1(6):509-15. PubMed ID: 3562444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor (EGF) fails to stimulate pancreatic growth and pancreatic polyamine metabolism in rats.
    Löser C; Fölsch UR
    Z Gastroenterol; 1994 Apr; 32(4):216-20. PubMed ID: 8017096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.